Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,099 | 18,813 | 12,629 | 34,959 | 141,075 |
| Marketable Securities | 104,529 | 72,247 | 84,185 | 70,622 | 0 |
| Receivables | N/A | 45,343 | N/A | N/A | N/A |
| TOTAL | $183,749 | $139,736 | $100,482 | $107,101 | $142,550 |
| Non-Current Assets | |||||
| PPE Net | 1,372 | 1,527 | 1,674 | 1,785 | 1,695 |
| Investments And Advances | 39,064 | 9,120 | 18,316 | 25,549 | 0 |
| Other Non-Current Assets | 9,295 | 9,435 | 9,505 | 9,655 | 9,788 |
| TOTAL | $49,731 | $20,082 | $29,495 | $36,989 | $11,483 |
| Total Assets | $233,480 | $159,818 | $129,977 | $144,090 | $154,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,594 | 4,567 | 3,742 | 2,526 | 1,318 |
| Accounts payable and accrued liabilities | 1,839 | 1,393 | 466 | 582 | 742 |
| Accrued Expenses | 8,653 | 4,614 | 3,953 | 5,777 | 5,065 |
| TOTAL | $63,933 | $60,246 | $43,367 | $41,167 | $35,849 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,547 | 5,707 | 6,458 | 7,602 | 8,741 |
| Deferred Revenues | 48,100 | 48,957 | 34,522 | 31,627 | 28,505 |
| Other Non-Current Liabilities | 11,214 | 11,413 | 11,608 | 11,815 | 11,987 |
| TOTAL | $46,722 | $55,741 | $33,316 | $40,765 | $50,716 |
| Total Liabilities | $110,655 | $115,987 | $76,683 | $81,932 | $86,565 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,220 | 23,915 | 23,915 | 23,882 | 23,803 |
| Common Shares | 29 | 24 | 24 | 24 | 24 |
| Retained earnings | -151,032 | -137,538 | -126,509 | -115,866 | -109,524 |
| Other shareholders' equity | 15 | 45 | 33 | 53 | -41 |
| TOTAL | $122,825 | $43,831 | $53,294 | $62,158 | $67,468 |
| Total Liabilities And Equity | $233,480 | $159,818 | $129,977 | $144,090 | $154,033 |